articleNew England Journal of MedicineJan 17, 2002BRONZE OA

Premyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis

Cleveland Clinic · West Los Angeles College

PubMed
Indexed incrossrefpubmed

Abstract

Background

Multiple sclerosis is an inflammatory disease of the central nervous system that destroys myelin, oligodendrocytes, and axons. Since most of the lesions of multiple sclerosis are not remyelinated, enhancement of remyelination is a possible therapeutic strategy that could perhaps be achieved with the transplantation of oligodendrocyte-producing cells into the lesions. We investigated the frequency distribution and configuration of oligodendrocytes in chronic lesions of multiple sclerosis to determine whether these factors limit remyelination.

Methods

Forty-eight chronic lesions obtained at autopsy from 10 patients with multiple sclerosis were examined immunocytochemically for oligodendrocytes and oligodendrocyte progenitor cells. Using confocal microscopy, we examined the three-dimensional relations between axons and the processes of premyelinating oligodendrocytes.

Citation impact

984
total citations
FWCI
12.66
Percentile
100%
References
39
Citations per year

Authors

4

Topics & keywords

Keywords
  • Remyelination
  • Multiple sclerosis
  • Oligodendrocyte
  • Myelin
  • Medicine
  • Pathology
  • Demyelinating disease
  • Central nervous system
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.